Background: The transcatheter closure of the atrial septal defect (ASD) has become an alternative technique to surgical procedures. The aim of this study was to assess the immediate, short, and intermediate-term results of the transcatheter closure of the secundum ASD with the Amplatzer Septal Occluder (ASO) in adult Iranian patients. Methods: Between December 2004 and July 2008, the transcatheter closure of the ASD using the ASO was attempted in 58 consecutive, adult patients. The mean age of the patients was 37.1 ± 12.7 years (range = 19- 75 years). All the procedures were performed under local anesthesia with transthoracic or transesophageal echocardiography and fluoroscopic guidance. The stretched diameter of the ASD was determined with...
Background : The purpose of this study is to assess the current management of atrial septal defect c...
Copyright © 2012 Chodchanok Vijarnsorn et al. This is an open access article distributed under the C...
Background: The AMPLATZER Septal Occluder (ASO) has successfully replaced surgery for the repair of ...
Atrial septal defect (ASD) was first described by Rokitansky 1 in 1875, but its clinical data were o...
Atrial septal defect (ASD) was first described by Rokitansky 1 in 1875, but its clinical data were o...
Purpose: This study reports the clinical experience and midterm outcomes of transcatheter closure of...
Background : The purpose of this study is to assess the current management of atrial septal defect c...
Background : The purpose of this study is to assess the current management of atrial septal defect c...
Objectives: We studied immediate and midterm results of transcatheter closure of atrial septal defec...
Objectives: Atrial Septal Defect (ASD) accounts for 10% of congenital cardiac defects. The purpose o...
Objectives: To report the initial clinical experience with a novel atrial septal defect (ASD) closur...
Purpose: We reviewed our experience in the closure of right-to-left atrial shunts using Amplatzer se...
Six female patients aged from 19 to 73 years, with ostium secundum atrial septal defect underwent cl...
Background: The AMPLATZER Septal Occluder (ASO) has successfully replaced surgery for the repair of ...
OBJECTIVE: This study aims to analyse the collective experience of participating European Congenita...
Background : The purpose of this study is to assess the current management of atrial septal defect c...
Copyright © 2012 Chodchanok Vijarnsorn et al. This is an open access article distributed under the C...
Background: The AMPLATZER Septal Occluder (ASO) has successfully replaced surgery for the repair of ...
Atrial septal defect (ASD) was first described by Rokitansky 1 in 1875, but its clinical data were o...
Atrial septal defect (ASD) was first described by Rokitansky 1 in 1875, but its clinical data were o...
Purpose: This study reports the clinical experience and midterm outcomes of transcatheter closure of...
Background : The purpose of this study is to assess the current management of atrial septal defect c...
Background : The purpose of this study is to assess the current management of atrial septal defect c...
Objectives: We studied immediate and midterm results of transcatheter closure of atrial septal defec...
Objectives: Atrial Septal Defect (ASD) accounts for 10% of congenital cardiac defects. The purpose o...
Objectives: To report the initial clinical experience with a novel atrial septal defect (ASD) closur...
Purpose: We reviewed our experience in the closure of right-to-left atrial shunts using Amplatzer se...
Six female patients aged from 19 to 73 years, with ostium secundum atrial septal defect underwent cl...
Background: The AMPLATZER Septal Occluder (ASO) has successfully replaced surgery for the repair of ...
OBJECTIVE: This study aims to analyse the collective experience of participating European Congenita...
Background : The purpose of this study is to assess the current management of atrial septal defect c...
Copyright © 2012 Chodchanok Vijarnsorn et al. This is an open access article distributed under the C...
Background: The AMPLATZER Septal Occluder (ASO) has successfully replaced surgery for the repair of ...